An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
for Pulmonary Arterial Hypertension
Sites in Durham +14 more locations
Sponsor: Inhibikase Therapeutics
Sex: All·Age: 18 - 75
Code: NCT07365332·Phase 3·Recruiting·Listed Jan 2026